1 Comment

In a conversation with Dayton Judd, I dropped the question about whether M&A scope may be broadened to encompass opportunities in other sectors.

The response was both emphatic and encouraging, "Our focus is definitely on the supplement space for right now. There are a lot of opportunities, and we have the platform and expertise to absorb them without learning a new industry or dramatically expanding our team."

This suggests that acquisitive growth is certain to continue and that FitLife will continue to grow. This company ought to be seen as a consolidation machine within a niche industry.

Expand full comment